Cryo-Cell

CCEL

4.7502.15% ( +0.100 )

Closed: Oct 20, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -19.27, within the reasonable range, cheaper than 78.9% of the time in the past 3 years, and the industry ranks 53/74, the industry Median --.

-19.27xP/E

Stock price$4.65Earnings per share$-0.24

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
GHUSGuardant Health	-46.73x	2.97%	$21.19B
HIMSUSHims & Hers Health	-46.24x	209.86%	$6.57B
RDNTUSRadnet	-258.16x	128.00%	$5.45B
NEOUSNeogenomics	-40.66x	64.12%	$2.11B
WGSUSGeneDx	-18.59x	359.59%	$1.98B
AGLUSagilon health	-6.42x	92.48%	$1.49B
INNVUSInnovage	-477.61x	2,301.70%	$1.21B
OPKUSOpko Health	-16.48x	25.99%	$1.20B
LMRIUSLumexa Imaging	-37.14x	145.51%	$1.03B
CSTLUSCastle Biosciences	-50.61x	51.54%	$982.62M
FLGTUSFulgent Genetics	-6.55x	42.64%	$553.06M
GMRSUSGMR Solutions	-7.13x	91.45%	$539.14M
AONCUSAmerican Oncology Network	--	--	$372.75M
PREUSPrenetics Global	-6.94x	15.02%	$326.07M
BDSXUSBiodesix	-8.89x	42.77%	$246.90M
GAMGUSGlobal Asset Management Group, Inc.	-382.76x	--	$216.04M
NAKAUSNakamoto	-0.31x	102.50%	$129.38M
CORBFUSGlobal Cord Blood Corporation	--	--	$127.35M
PARKUSPark Dental Partners	-25.40x	--	$89.78M
AIRSUSAirSculpt Tech	-7.65x	33.33%	$89.76M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.